Dermatofibrosarcoma protuberans treated by micrographic surgery by Ah-Weng, A et al.
Dermatoﬁbrosarcoma protuberans treated by
micrographic surgery
A Ah-Weng
1, JR Marsden*
,1, DSA Sanders
1 and R Waters
1
1Skin Oncology Service, University Hospital Birmingham NHS Trust, Birmingham B29 6JD, UK
Dermatoﬁbrosarcoma protuberans is an uncommon cutaneous tumour which rarely metastasises. However, local recurrence
following apparently adequate surgical excision is well recognised, presumably as a result of sub-clinical contiguous growth, for
which micrographically controlled excision would be a logical treatment. A retrospective study of all patients treated by
micrographic surgery, from April 1995–March 2000, at a tertiary skin oncology centre. Twenty-one patients (11 males), age
14 to 71 years with dermatoﬁbrosarcoma protuberans on the trunk (10 patients), groin (four), head and neck (four), and
limbs (three) were treated. In 15 patients one micrographic layer cleared the tumour, and four were cleared with two layers.
For one patient the second stage was completed by conventional excision guided by positive margins. Another patient with a
multiply recurrent perineal dermatoﬁbrosarcoma protuberans, not cleared in one area after two layers, died from a pulmonary
embolus before total clearance could be achieved. There was no correlation between tumour size and lateral excision margin.
No recurrence was observed during the follow-up, from 21 to 80 months, median 47 months. The study provides further
support for micrographic surgery as the treatment of choice for dermatoﬁbrosarcoma protuberans.
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Dermatoﬁbrosarcoma protuberans (DFSP) is an uncommon ﬁbro-
sarcoma which appears to originate from dermal ﬁbroblasts
(Taylor and Helwig, 1962; Lautier et al, 1990). It grows slowly
and contiguously with wide extension between adjacent collagen
bundles, and not infrequently into the underlying fascia and
muscle. These microscopic inﬁltrations may not be clinically appar-
ent, and can be missed on histology by using conventional serial
vertical sections.
Regional and distant metastases from DFSP do occur but are
rare, probably less than 1% (Smola et al, 1991), and certainly lower
than previous estimates of 4–6% (Roses et al, 1986; Rutgers et al,
1992). Distant metastases to the lung, even up to 9 years after
primary excision, have been described (Taylor and Helwig, 1962).
The risk of metastasis appears to increase with repeated incomplete
excision and de-differentiation towards a higher-grade ﬁbrosarco-
ma (Taylor and Helwig, 1962). Fatalities from direct intra-
cerebral invasion have also been reported (McPeak et al, 1967;
Barnes and Coleman, 1984).
Treatment of DFSP by local excision consistently results in high
recurrence rates of 30–76% (Taylor and Helwig, 1962; McPeak et
al, 1967; Hajdu, 1979; Smola et al, 1991; Mark et al, 1993). The
recommended approach has been wide local excision with lateral
margins of at least 3 cm and including the underlying fascia
(McPeak et al, 1967; Bendix-Hansen et al, 1983; Roses et al,
1986; Rutgers et al, 1992). Larger margins do produce better clear-
ance rates but a corresponding greater loss of tissue as there is no
reason to believe that the tumour growth is concentric with the
clinical margin. A lateral margin of 3 cm results in a local recur-
rence rate of 10–20% (McPeak et al, 1967; Roses et al, 1986;
Gloster et al, 1996) and at 4 cm a recurrence rate of 6% was found
in 96 patients (Petoin et al, 1985). Of 58 cases, even a 10 cm exci-
sion width would not have cleared the tumour in two patients
(Ratner et al, 1997).
The aim of treatment should be complete tumour clearance and
maximum preservation of normal tissue. Micrographic controlled
excision (MCE) of skin tumours allows examination of all surgical
margins, and preliminary evidence for DFSP suggested this method
to be effective (Mikhail and Lynn, 1978; Robinson, 1985; Parker and
Zitelli, 1995). Results from subsequent series and retrospective
studies show a consistently high rate for complete clearance in both
primary and recurrent tumours (Hobbs et al, 1988; Dawes and
Hanke, 1996; Gloster et al, 1996; Haycox et al, 1997; Ratner et al,
1997). Together these reports appear to indicate support for MCE
as the most appropriate treatment of DFSP. We present the results
of all our patients in support of MCE as the treatment of choice
for DFSP.
MATERIALS AND METHODS
Clinical data
Diagnosis of DFSP was conﬁrmed histologically and on positive
CD34 staining by an experienced dermatohistopathologist (DSAS).
Twenty-one patients with DFSP were treated by MCE, undertaken
by one operator (JR Marsden), from April 1995 to March 2000.
The following characteristics recorded include age at presentation,
sex, duration of tumour, clinical size, site and any prior attempt at
excision. Also details of inpatient or outpatient care, mode of
anaesthesia used, number of micrographic stages, margin and
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tional outcome, were documented. Each subject was recalled for a
ﬁnal outpatient review to corroborate clinical information and
update clinical outcome.
Operative method
The tumour or residual scar tissue was debulked prior to MCE. A
modiﬁed Mohs micrographic surgical procedure which utilised
formalin-ﬁxed, parafﬁn embedded tissue for an improved interpre-
tation of histology of soft-tissue tumours was employed (Clayton et
al, 2000). Micrographic layers of 2–3 mm thick were excised to
give an initial 1 cm lateral excision margin from the tumour or
scar margin, except in one patient where the initial margin was
0.5 cm. The ﬁrst layer was resected down to the deep fascia.
Guided by histologically positive margins, subsequent micrographic
layers were excised at 1 cm intervals to minimise the total number
of resection stages. These were divided, colour-coded, orientated in
tissue cassettes, ﬁxed and embedded in parafﬁn before staining
with haematoxylin and eosin, and for CD34. Sections were
reported within 20 h, if necessary further MCE was performed
within 24 h until clearance. Analysis for statistical correlation
between tumour diameter and lateral excision was undertaken by
Minitab statistical package.
RESULTS
Clinical characteristics
Of the 21 patients, 11 were male, and the age at presentation 36
(14–71) years, median (range). The duration of onset to presenta-
tion was 24 months (6 months to 30 years). Maximum tumour
diameter was 3.25 (1.5–16) cm. Clinically, most were typical indu-
rated rubbery pale brown/pink plaques with a smooth surface and
often studded with multiple nodules. The sites of presentation were
the trunk (10 patients), groin (four), head and neck (four), and
limbs (three). The commonest site was upper chest (seven patients).
Most patients were referred with a primary DFSP, however ﬁve
patients presented with recurrent tumours. Of these three recurred
within 18 months of the initial local excision, one had re-grown
slowly over the site of an incompletely excised DFSP 20 years
previously, and another had a repeatedly recurrent perineal tumour
treated unsuccessfully by wide local excision on at least three occa-
sions over 15 years. Eleven were referred from their primary care
physician, the majority of whom had not yet had a histological
diagnosis. The other patients were sent after a diagnosis had been
established on histology. Seven patients had undergone previous
resection of the primary tumour which were histologically incom-
pletely excised, and at tertiary consultation showed no visible or
palpable tumour.
Results of micrographic surgery
To achieve the clearance of tumour in 21 patients, 15 required only
one micrographic layer, and four needed a second layer. In two
other patients, however, total clearance could not be assessed.
One had extensive sub-clinical involvement in six out of nine
micrographic samples over both lateral and deep margins after
the ﬁrst micrographic layer. Further surgery under local anaesthesia
was not possible due to the extent of the lesion and its complex
site in the supraclavicular fossa and root of neck. The second exci-
sion layer was directed by histologically positive margins, but
carried out conventionally. In the other patient a large multiply
recurrent perineal DFSP was not cleared in the deep margin after
the second micrographic layer. Unfortunately, he died on the
10th post-operative day from a pulmonary embolus before further
micrographic surgery could be undertaken.
Of those cleared after a second layer, two patients required a
micrographic layer to both lateral and deep margins, and in the
other two further layers to the deep margin only. Further resection
to the deep margin involved partial excision of the sternomastoid
muscle, full thickness dartos muscle, rectus sheath and full-thickness
occipital bone. With the addition of the lateral margin from a prior
excision biopsy, measuring 0.5–1.5 cm, recorded in three patients,
the total margin of lateral clearance ranged from 0.5 to a maximum
of 2.5 cm, median 1.5 cm. This corresponds to a clearance of 0.5 cm
in one patient (5%), 1 cm in 12 patients (56%), 1.5 cm for four
(19%), 2 cm in one (5%), and 2.5 cm in another (5%). In our
cohort, there was no signiﬁcant statistical correlation evident
between maximal tumour size and lateral margin necessary for
complete excision (Spearman rank correlation=0.043; P=0.854,
n=21) (Figure 1). For the ﬁrst micrographic layer, a median of 12
samples were processed, range four to 76, and in the second layer,
a median of six samples, range two to 15.
Sixteen patients were treated under local anaesthesia, ﬁve needed
regional or general anaesthesia which included the youngest or
those with the largest tumours. Twelve were managed as outpatient
cases in the day surgical unit, and nine patients required further in-
patient care, admission duration 2 (1–10) days, including those
who had general anaesthesia.
For 15 patients the surgical defects were closed directly. Four
required split skin grafts, one to an overlying pectoralis muscle
ﬂap. A patient needed a cavarial graft followed by a scalp rotation
ﬂap. Except for the fatality which occurred despite prophylaxis for
deep vein thrombosis, the only other early post-operative compli-
cation was transient ﬂexion weakness and paraesthesia of the
ﬁngers developing distal to the surgical site. At follow-up cosmesis
was assessed by the attending physician. In 16 patients the wound
cosmesis was described as very good, four as fair compromised by
split skin grafts, stretched scars and in another a hypertrophied scar
treated satisfactorily with intra-lesional triamcinolone. No perma-
nent functional deﬁcit was noted. There was no recurrence
observed during the follow-up interval 47 (21–80) months.
DISCUSSION
DFSP represents about 1% of all soft tissue sarcomas with an esti-
mated incidence of 0.8/million (Bendix-Hansen et al, 1983). A
higher standardised incidence rate of 4.5/million from 1970 to
1984, based on crude rates of four female cases was reported in
the Rochester population (Tsu et al, 1990). In comparison, age
standardised incidence data from the West Midlands Cancer Intel-
ligence Unit showed a mean annual rate of 1.8/million for the
region between the period 1984 to 1998 (personal communication,
Dr Cheryl Hyde) on a crude rate of 142 histologically conﬁrmed
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Figure 1 Correlation of maximal tumour diameter to lateral excision
margin
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dised incidence of 2.1/million for males and 1.5/million for
females, which conﬁrms the previously suggested male predomi-
nance in several case series (Pack and Tabah, 1951: Taylor and
Helwig, 1962; McPeak et al, 1967).
The median age at presentation of 36 years is comparable to
other reports which observed onset from the third to ﬁfth decade
(Taylor and Helwig, 1962; McPeak et al, 1967). As expected, the
time to presentation extends from weeks to decades but was usual-
ly several years (McPeak et al, 1967). The tumour has been
described on almost every site on the body surface, typically as
an indurated dermal and subcutaneous plaque or nodule. Consis-
tent with previous observations the commonest area in half of all
cases was the upper trunk, especially the supra-clavicular fossa
(Pack and Tabah, 1951; Taylor and Helwig, 1962; McPeak et al,
1967, Roses et al, 1986; Hajdu, 1979). There are reports describing
a history of trauma in 10–20% of cases preceding the develop-
ment of DFSP (Pack and Tabah, 1951; Taylor and Helwig,
1962). In one of our patients the tumour developed within an
old burn scar, and another after a scarring spade injury to his
shoulder.
In our study, all the tumours could be completely resected with
2.5 cm lateral margins, but this does not include four out of seven
patients who had a prior diagnostic excision biopsy where the
lateral margins were not recorded. Other studies of Mohs micro-
graphic excision for DFSP showed a comparable clearance rate
for lateral margins (Table 1).
Tumour extension into the deep fascia is a common ﬁnding and
is associated with recurrence. In a series of 20 patients all tumours
were cleared by micrographic excision of deep fascia and superﬁcial
muscle layer, with those over the forehead and scalp through the
periosteum (Parker and Zitelli, 1995). Of 10 patients treated by
micrographic surgery, four had invaded muscle of whom two
had periosteum involvement (Hobbs et al, 1988). In four cases
described by Robinson, two had extended into superﬁcial muscle
and the others localised in fascia (Robinson, 1985). Excision of
fascia were undertaken in six out of 16 (27%) where the tumour
recurred, compared to 23 (72%) out of 32 in whom tumour did
not recur (Roses et al, 1986).
We found no statistical relationship between tumour size and
required margin of excision but four patients had prior unrecorded
excision biopsy margins. Similarly, in those ﬁve patients with
recurrent tumours, the size would be underestimated by preceding
attempts at clearance. Other studies have not observed a relation-
ship of maximum tumour size to excision margin (Roses et al,
1986; Ratner et al, 1997). However, one report found tumours less
than 2 cm could be safely excised by a 1.5 cm lateral margin (n=9),
as opposed to those greater than 2 cm which needed 2.5 cm
margin (n=11) (Parker and Zitelli, 1995). Although in this study
eight were recurrent tumours, and the number who had a prior
diagnostic biopsy were not speciﬁed.
To date no recurrence of DFSP following micrographically
controlled excision have been observed after a follow-up interval
of 38 (12–71) months in our series. From previous studies of
conventional local excision, the majority of recurrences developed
early after resection. Approximately half presented within 2 years,
and 80% within 3 years (McPeak et al, 1967). Of 20 patients six
recurred at 21 (6–36) months for lateral margins of 1–3 cm
(Smola et al, 1991). In 98 cases, a 49% recurrence was observed
after local resection; 40% within the ﬁrst year, and 75% in the ﬁrst
3 years (Taylor and Helwig, 1962). Similar recurrence rates were
found by McPeak in 82 patients, and a series of 119 patients trea-
ted by wide excision (McPeak et al, 1967; Hajdu, 1979). The head
and neck is a more common site for recurrence, and it is unclear
whether this reﬂects the difﬁculties in excising DFSP over this area
(Barnes and Coleman, 1984; Mark et al, 1993). A small number of
patients, however, present with a very delayed recurrence, up to 20
years after excision (McPeak et al, 1967; Mikhail and Lynn, 1978;
Roses et al, 1986). Of our group, one patient presented with a
DFSP on her forehead, at the site of a previously suspected DFSP
excised over 20 years earlier.
The current evidence to support MCE for the treatment of DFSP
derives from case observations and retrospective studies (Dawes
and Hanke, 1996; Haycox et al, 1997). The largest study incorpo-
rates grouped data of 50 patients from several centres (Ratner et al,
1997). Haycox et al (1997) reviewed the world-wide literature and
found a mean recurrence rate of 2.4% from a total of 169 reported
cases. Although most series describe no recurrences the highest
reported rate was two out of 24 cases (8.3%) (Dawes and Hanke,
1996), with two other groups each having had one recurrence in 15
(6.6%) and 50 (2%) patients followed-up (Gloster et al, 1996;
Ratner et al, 1997).
Recent retrospective series have revealed promising results for
adjuvant radiotherapy in preventing local recurrence of incomple-
tely excised DFSP but its role yet remains to be established (Haas et
al, 1997; Linder et al, 1999).
For day surgery under local anaesthetic, an estimated cost of
wide local excision at £460 compared well with one stage of
MCE at £560, the only treatment required in 12 patients. Of the
nine patients who required overnight stay after MCE the total cost
for each was estimated at £1770 per day inclusive of general anaes-
thesia. The operative time is not any longer for MCE but
processing the specimen takes 10–25 min per micrographic layer.
Histopathology reporting of micrographic sections is considerably
more demanding, from ﬁve to 10 times longer than conventional
sections, depending on the number of samples. The higher cost
of MCE, however, would be outweighed by the improved surgical
outcome and prognosis.
In summary, our data provides further support for the favour-
able outcome following margin control in the excision of DFSP.
This approach demonstrates very low recurrence rate with opti-
mum conservation of normal tissue, and would be the treatment
of choice for DFSP.
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Table 1 Studies which showed the percentage of DFSP cleared at lateral excision margin
No. of
Margin (cm) with % of tumour cleared
Citation patients 0.5 1.0 1.5 2.0 2.5 3.0 5.0
Current study, 2000 21 5 61 80 85 100
Dawes and Hanke, 1996 24 – 35 50 69 85
Gloster et al, 1996 18 22 50 67 89
Parker and Zitelli, 1995 20 – 75 80 85 100
Ratner et al, 1997 50 – 29.3 – 60.3 – 84.5 94.8
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